Exercise and Two Different Kinesiotape Applications in Patients With Sacroiliac Joint Dysfunction
1 other identifier
interventional
99
1 country
1
Brief Summary
This study is a randomized controlled study. 99 patients between the ages of 18-65 who were diagnosed with sacroiliac joint dysfunction will be included in the study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2016
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2016
CompletedFirst Submitted
Initial submission to the registry
March 29, 2021
CompletedFirst Posted
Study publicly available on registry
April 2, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 20, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
July 20, 2024
CompletedAugust 21, 2024
August 1, 2024
7.6 years
March 29, 2021
August 19, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
Pain at rest
Pain at rest will be measured using the Visuel Analog Scale (0-10 cm).Patients are asked to rate their pain at rest over the past week and to mark a point on a 10 cm line with endpoints '0 = no pain' and '10 = worst pain imaginable'. The distance (cm) measured from the 'no pain' endpoint to the point marked by the patient is reported as the VAS score.
Before treatment (T1), After treatment at 4th week (T2), Follow-up at 8th week (T3)
Pain at movement
Pain at movement will be measured using the Visuel Analog Scale (0-10 cm).Patients are asked to rate their pain at rest over the past week and to mark a point on a 10 cm line with endpoints '0 = no pain' and '10 = worst pain imaginable'. The distance (cm) measured from the 'no pain' endpoint to the point marked by the patient is reported as the VAS score.
Before treatment (T1), After treatment at 4th week (T2), Follow-up at 8th week (T3)
Secondary Outcomes (2)
Patient Global Assessment
Before treatment (T1), After treatment at 4th week (T2), Followup at 8th week (T3)
Oswestry Disability Index
Before treatment (T1), After treatment at 4th week (T2), Followup at 8th week (T3)
Study Arms (3)
Home Exercise
ACTIVE COMPARATORThe group will be given a home exercise programme involving flexibility and strengthening of the lower back, hip girdle and sacroiliac region.
Home Exercise and Ligament Correction Kinesiotaping
ACTIVE COMPARATORIn addition to the home exercise program, ligament correction kinesiotaping will be applied to the patients' sacroiliac region.
Home Exercise and Lymphatic Correction Kinesiotaping
ACTIVE COMPARATORIn addition to the home exercise program, lymphatic correction kinesiotaping will be applied to the patients' sacroiliac region.
Interventions
This is a home exercise programme that involves flexibility and strengthening of the waist, hip girdle and sacroiliac region. These exercises are first shown by the physiotherapist in hospital, and then they are asked to do the exercises at home using illustrated forms. Patients continue the exercises as a home programme once a day for 1 month.
Ligament correction kinesiotaping will be applied to the patients' sacroiliac region. Taping will be done once a week. It will be kept for 5 days. This application will be repeated 3 times.
Lymphatic correction kinesiotaping will be applied to the patients' sacroiliac region. Taping will be done once a week. It will be kept for 5 days. This application will be repeated 3 times.
Eligibility Criteria
You may qualify if:
- Patients with sacroiliac joint dysfunction between the ages of 18-65
You may not qualify if:
- Patients with rheumatological inflammatory disease
- Inflamatory sacroiliitis
- Patients with polyarthrosis, herniated disc, severe symptomatic disc degeneration, spinal stenosis and spondyloarthrosis.
- Patients with a history of pelvic trauma
- Patients with metabolic bone disease, infection, malignancy, pregnancy
- Patients with open wounds in the lumbar and sacral area
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ufuk Universitylead
Study Sites (1)
Ufuk University
Ankara, Turkey (Türkiye)
Study Officials
- PRINCIPAL INVESTIGATOR
saime ay
Ufuk University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
March 29, 2021
First Posted
April 2, 2021
Study Start
December 1, 2016
Primary Completion
July 20, 2024
Study Completion
July 20, 2024
Last Updated
August 21, 2024
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will not share